FEOLA, SARA
 Distribuzione geografica
Continente #
NA - Nord America 197
EU - Europa 183
AS - Asia 105
AF - Africa 5
Totale 490
Nazione #
US - Stati Uniti d'America 196
IT - Italia 81
FR - Francia 53
SG - Singapore 52
IN - India 39
NL - Olanda 32
CN - Cina 13
FI - Finlandia 8
DE - Germania 5
CI - Costa d'Avorio 4
IE - Irlanda 2
SE - Svezia 2
CA - Canada 1
IR - Iran 1
ZA - Sudafrica 1
Totale 490
Città #
Singapore 45
Delhi 38
Santa Clara 34
Amsterdam 32
Millbury 23
Naples 17
Lawrence 14
Napoli 12
Chandler 10
Des Moines 7
Helsinki 5
Ashburn 4
Sesto Fiorentino 4
Boston 3
Lappeenranta 3
Rome 3
Acerra 2
Beijing 2
Ercolano 2
Munich 2
Nanchang 2
Nanjing 2
San Paolo Bel Sito 2
Shanghai 2
Villarosa 2
Wilmington 2
Abbiategrasso 1
Bethesda 1
Dallas 1
Fairfield 1
Falkenstein 1
Florence 1
Hebei 1
Jiaxing 1
Johannesburg 1
Lissone 1
Loreto 1
Ottawa 1
Portici 1
Potenza 1
Pozzuoli 1
Princeton 1
Redwood City 1
San Francisco 1
San Jose 1
San Sebastiano al Vesuvio 1
Stockholm 1
Taramani 1
Torre Annunziata 1
Turin 1
Woodbridge 1
Wuhan 1
Totale 300
Nome #
A novel in silico framework to improve MHC-I epitopes and break the tolerance to melanoma 134
Peptide Nucleic Acid-Functionalized Adenoviral Vectors Targeting G-Quadruplexes in the P1 Promoter of Bcl-2 Proto-Oncogene: A New Tool for Gene Modulation in Anticancer Therapy 65
Biohybrid Vaccines for Improved Treatment of Aggressive Melanoma with Checkpoint Inhibitor 31
Personalized Cancer Vaccine Platform for Clinically Relevant Oncolytic Enveloped Viruses 30
Systems Biology Approaches for the Improvement of Oncolytic Virus-Based Immunotherapies 28
Artificially cloaked viral nanovaccine for cancer immunotherapy 26
A novel immunopeptidomic-based pipeline for the generation of personalized oncolytic cancer vaccines 22
Tumor suppressor role of hsa-mir-193a-3p and-5p in cutaneous melanoma 21
PeptiCHIP: A Microfluidic Platform for Tumor Antigen Landscape Identification 20
Viral molecular mimicry influences the antitumor immune response in murine and human melanoma 19
Uncovering the tumor antigen landscape: What to know about the discovery process 18
Exploiting preexisting immunity to enhance oncolytic cancer immunotherapy 18
Oncolytic adenovirus drives specific immune response generated by a poly-epitope pDNA vaccine encoding melanoma neoantigens into the tumor site 17
Harnessing therapeutic viruses as a delivery vehicle for RNA-based therapy 14
Therapeutic cancer vaccination with immunopeptidomics-discovered antigens confers protective antitumor efficacy 14
Bifidobacterium affects antitumor efficacy of oncolytic adenovirus in a mouse model of melanoma 12
PeptiVAX: A new adaptable peptides-delivery platform for development of CTL-based, SARS-CoV-2 vaccines 11
Novel personalized cancer vaccine platform based on Bacillus Calmette-Guèrin 11
A novel in silico framework to improve MHC-I epitopes and break the tolerance to melanoma (vol 6, e1319028, 2017) 10
Totale 521
Categoria #
all - tutte 2.884
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.884


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20209 0 0 0 0 2 2 2 0 0 1 2 0
2020/202125 1 0 6 0 1 0 0 10 7 0 0 0
2021/202276 0 0 0 2 0 2 1 3 15 0 17 36
2022/2023119 15 4 2 0 14 11 0 8 12 30 3 20
2023/2024136 22 34 15 6 10 7 6 10 1 2 17 6
2024/2025104 38 37 3 6 20 0 0 0 0 0 0 0
Totale 521